ConductScience.org, home

Paper2432012

Effect of CI-922, a potential new antiallergy agent, on arachidonic acid metabolism in vitro.

Boctor AM and 1 other. Inflammation, 1986. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effect of CI-922, a potential new antiallergy agent, on arachidonic acid metabolism in vitro. Papers, record 2432012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2432012

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of CI-922, a potential new antiallergy agent, on arachidonic acid metabolism in vitro.
PubMed
Journal
Inflammation
PubMed
Year
1986
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2019-09-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boctor AMA M
2Pugsley TAT A

Source PubMed

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arachidonic AcidsMajor topic
AzolesMajor topic
Histamine ReleaseMajor topic
IndolesMajor topic
LeukocytesMajor topic
TetrazolesMajor topic
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine
Adult
Animals
Arachidonate 5-Lipoxygenase
Arachidonic Acid
Calcimycin
Cattle
Humans
Hydroxyeicosatetraenoic Acids
In Vitro Techniques
Indomethacin
Male
Masoprocol
Pyrazoles
Seminal Vesicles

Source PubMed

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,962,465Prostaglandin endoperoxide metabolism by microsomes of whole kidneys from normal, congenital unilateral hydronephrotic and unilateral ureteral obstructed rats.Prostaglandins1982https://conductscience.org/library/papers/6962465PubMed
26,301,011Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.Science1983https://conductscience.org/library/papers/6301011PubMed
3110,332A new approach to anti-inflammatory drugs.Biochem Pharmacol1979https://conductscience.org/library/papers/110332PubMed
4377,292Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/377292PubMed
56,781,575The pharmacology of isamoxole [2-methyl-n-butyl-n(4-methyloxazol-2-yl) propanamide] LRCL 3950, a new anti-allergic compound.Br J Pharmacol1980https://conductscience.org/library/papers/6781575PubMed
66,221,723Differential effects of anti-inflammatory drugs on lipoxygenase and cyclo-oxygenase activities of neutrophils from a reverse passive Arthus reaction.Biochem Biophys Res Commun1983https://conductscience.org/library/papers/6221723PubMed
76,171,522Control mechanisms of histamine release from human basophils in vitro: the role of phospholipase A2 and of lipoxygenase metabolites.Int Arch Allergy Appl Immunol1981https://conductscience.org/library/papers/6171522PubMed
86,417,727Inhibition of human neutrophil arachidonate 5-lipoxygenase by 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin I1 (U-60257).Prostaglandins1983https://conductscience.org/library/papers/6417727PubMed
9382,802FPL 55712 -- an antagonist of slow reacting substance of anaphylaxis (SRS-A): a review.Agents Actions1979https://conductscience.org/library/papers/382802PubMed
106,405,452Selective inhibition of the lipoxygenase metabolic pathway of arachidonic acid by the SRS-A antagonist, FPL 55712.Prostaglandins1983https://conductscience.org/library/papers/6405452PubMed
113,020,588Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro.Prostaglandins Leukot Med1986https://conductscience.org/library/papers/3020588PubMed
1241,912Inhibition of rabbit PMN lipoxygenase activity by benoxaprofen.J Pharm Pharmacol1979https://conductscience.org/library/papers/41912PubMed
136,191,762In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin.Biochem Pharmacol1983https://conductscience.org/library/papers/6191762PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ALOX5240PubTator's text mininghttps://conductscience.org/library/genes/240

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2432012

GET https://conductscience.org/api/papers/v1/2432012/authors